Insider Selling: Omnicell VP Sells 6,250 Shares of Stock (OMCL)
Omnicell (NASDAQ:OMCL) VP Dan S. Johnston unloaded 6,250 shares of the stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $28.00, for a total transaction of $175,000.00. Following the completion of the sale, the vice president now directly owns 71,296 shares in the company, valued at approximately $1,996,288. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
A number of analysts have recently weighed in on OMCL shares. Analysts at Zacks upgraded shares of Omnicell from a “neutral” rating to an “outperform” rating in a research note on Friday, August 8th. They now have a $32.00 price target on the stock. Separately, analysts at Topeka Capital Markets reiterated a “buy” rating on shares of Omnicell in a research note on Tuesday, July 29th. Finally, analysts at Topeka Capital Markets initiated coverage on shares of Omnicell in a research note on Thursday, June 12th. They set a “buy” rating and a $30.00 price target on the stock. Seven analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and a consensus target price of $31.50.
Shares of Omnicell (NASDAQ:OMCL) traded up 0.43% during mid-day trading on Wednesday, hitting $28.04. 123,355 shares of the company’s stock traded hands. Omnicell has a 1-year low of $20.88 and a 1-year high of $30.33. The stock has a 50-day moving average of $27. and a 200-day moving average of $27.51. The company has a market cap of $1.006 billion and a price-to-earnings ratio of 35.89.
Omnicell (NASDAQ:OMCL) last released its earnings data on Thursday, July 31st. The company reported $0.30 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.29 by $0.01. The company had revenue of $105.10 million for the quarter, compared to the consensus estimate of $103.23 million. During the same quarter in the prior year, the company posted $0.27 earnings per share. The company’s quarterly revenue was up 12.2% on a year-over-year basis. On average, analysts predict that Omnicell will post $1.23 earnings per share for the current fiscal year.
Omnicell, Inc (NASDAQ:OMCL) is a provider of automated solutions for hospital medication and supply management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.